Keyphrases
Hypoxic-ischemic Brain Injury
100%
Allopurinol
80%
Deferoxamine
80%
Neutrophils
60%
Energy Metabolites
40%
Blood-brain Barrier
40%
Hydroxyl Radical
40%
Hypoxia-ischemia
40%
Capillary Occlusion
40%
Xanthine Oxidase
40%
Postnatal Rat
20%
Specific Intent
20%
Hydroxylation
20%
Perinatal Brain Injury
20%
Perinatal Period
20%
Lipid Hydroperoxides
20%
Microvascular Function
20%
Neuroprotective Mechanisms
20%
Biochemical Analysis
20%
Rescue Treatment
20%
Metabolite Pharmacokinetics
20%
Brain Injury
20%
Product-specific
20%
Therapeutic Window
20%
Cerebral Edema
20%
Human Infants
20%
Oxidative Damage
20%
Salicylate
20%
Brain Energy
20%
Treatment Protocol
20%
Regional Cerebral Blood Flow (rCBF)
20%
Neutropenia
20%
Neuropathology
20%
Postnatal Age
20%
Analytical Procedures
20%
Lipid Peroxidation
20%
Oxygen Radicals
20%
Free Radicals
20%
Brain Water Content
20%
Rescue Therapy
20%
Cerebral Blood Flow
20%
Hydroxyl Radical Generation
20%
Cerebral Hypoxia-ischemia
20%
Free Radical Formation
20%
Neuroprotective
20%
Effective Treatment
20%
Neuroscience
Allopurinol
100%
Brain Injury
100%
Deferoxamine
100%
Free Radical
75%
Neuroprotective Agent
50%
Blood Brain Barrier
50%
Xanthine Oxidase
50%
Lipid Peroxidation
25%
Salicylate
25%
Cerebral Hypoxia
25%
Cerebral Edema
25%
Hydroxylation
25%
Common Carotid Artery
25%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoxic Ischemic Encephalopathy
100%
Deferoxamine
66%
Allopurinol
66%
Hydroxyl Radical
50%
Brain Injury
33%
Free Radical
33%
Xanthine Oxidase
33%
Neuroprotective Agent
33%
Therapeutic Window
16%
Lipid Hydroperoxide
16%
Tissue Extract
16%
Carotid Artery Obstruction
16%
Brain Edema
16%
Ischemia
16%
Hypoxia
16%
Salicylic Acid
16%
Neutropenia
16%
Oxygen Radical
16%